Takeda Pharmaceutical
TAK
#369
Rank
A$97.29 B
Marketcap
A$30.45
Share price
0.33%
Change (1 day)
44.33%
Change (1 year)

Earnings for Takeda Pharmaceutical (TAK)

Earnings in 2026 (TTM): A$0.82 Billion

According to Takeda Pharmaceutical's latest financial reports the company's current earnings are A$29.55 Billion. In 2025 the company made an earning of A$4.80 Billion, an increase over its 2024 earnings that were of A$3.22 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Takeda Pharmaceutical from 2009 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$0.82 B-82.91%
2025 A$4.80 B49.03%
2024 A$3.22 B-2.41%
2023 A$3.30 B-28.14%
2022 A$4.59 B-40.9%
2021 A$7.77 B78.24%
2020 A$4.36 B246.1%
2019 A$1.26 B-48.79%
2018 A$2.46 B-23.64%
2017 A$3.22 B21.7%
2016 A$2.64 B-253.01%
2015 -A$1.74 Billion-159.65%
2014 A$2.90 B13%
2013 A$2.56 B2.46%
2012 A$2.50 B-57.05%
2011 A$5.83 B-10.49%
2010 A$6.51 B-3.99%
2009 A$6.78 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$27.03 B 3,523.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$18.25 B 2,347.22%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$9.97 B 1,236.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$14.85 B 1,891.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$10.33 B 1,285.97%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
A$11.10 B 1,388.50%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$10.33 B 1,284.84%๐Ÿ‡ฌ๐Ÿ‡ง UK
Seagen
SGEN
-A$1.15 Billion-253.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
A$0.61 B-17.25%๐Ÿ‡ฎ๐Ÿ‡ณ India